John Frank an Industry Leader in Sleep and Respiratory Care Joins the Sommetrics Board of Directors

May 19, 2023 | Press Releases

SAN DIEGO, Calif. — May 19, 2023 — Sommetrics, a private company developing solutions to improve sleep health by providing innovative first in class products to treat sleep apnea, today announced that Mr. John Frank was elected to its Board of Directors.  Mr. Frank...

Sommetrics Presents at 22nd Annual Needham Virtual Healthcare Conference

May 10, 2023 | Press Releases

SAN DIEGO, Calif. — May 10,  2023 — Sommetrics, a private company developing solutions to improve sleep health by providing innovative first in class products to treat sleep apnea, today announced that it made a presentation at the 22nd Annual Needham Virtual...

Sommetrics Presents Update on Pivotal SUPRA Sleep Apnea Trial at International Sleep and Breathing Conference

Mar 22, 2023 | Press Releases

SAN DIEGO, Calif. — March 22, 2023 — Sommetrics, a private company developing products and services to improve sleep health, today announced presentation of an interim update on its pivotal SUPRA study (Study Using Negative Pressure to Reduce Apnea) at the tri-annual,...

Sommetrics Provides Update on the Pivotal SUPRA Clinical Trial for Sleep Apnea and Recent Corporate Accomplishments

Apr 20, 2022 | Press Releases

VISTA, Calif. — April 20, 2022 — Sommetrics, a private company developing products and services to improve sleep health, today released an update on its key accomplishments during the first quarter of 2022.  Chief among these accomplishments was the Company’s...

Sommetrics Launches Pivotal Clinical Study of Its aerSleep II Product to Treat Sleep Apnea; Raises $11 Million in Series C Preferred Financing

Sep 29, 2021 | Press Releases

VISTA, Calif. — September 29, 2021 — Sommetrics, a private company developing products and services to improve sleep health, today announced the launch of the pivotal clinical trial of its aerSleep® II device for the treatment of obstructive sleep apnea (OSA). This...

Sommetrics Receives IDE Approval From the FDA to Begin SUPRA Trial of aerSleep II for Treating Sleep Apnea

Apr 29, 2021 | Press Releases

VISTA, Calif. — April 29, 2021 — Sommetrics is pleased to announce US Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application to conduct a pivotal in-home clinical trial of its aerSleep II system.  The Study Using negative...